Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability in ECOG-ACRIN Studies

  • Cella, David (PD/PI)
  • Estabrook, Christopher Ryne (Co-Investigator)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/18/18 → 8/31/23

Funding

  • Dana-Farber Cancer Institute (1204004 // 5U01CA233169-05 AMD6)
  • National Cancer Institute (1204004 // 5U01CA233169-05 AMD6)